Clinical trial
Effect of Increasing Testosterone on Insulin Sensitivity in Men With the…
NCT00438321 · Massachusetts General Hospital, Other · Terminated
Key facts
| NCT number | NCT00438321 |
|---|---|
| Title | Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome |
| Official title | Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Institutes of Health (NIH) NIH American Diabetes Association |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Metabolic Syndrome |
| Intervention type | Drug, Other |
| Interventions | Zoladex, Testosterone gel, Anastrozole Pill, Placebo |
| Enrollment | 66 |
| Start date | Sep 1, 2006 |
| Primary completion | Feb 26, 2010 |
| Completion | Feb 26, 2010 |
| First posted | Feb 22, 2007 |
| Last update posted | Apr 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: